Intragastric Balloon Top Companies-Recent Developments, Business Strategy, Deal Strategy, Patent Strategy, Benchmarking and Management Outlook

Date : November 2024

Intragastric Balloon Market Size Analysis and Top Companies

The global intragastric balloon market size is anticipated to reach around USD 108.80 million by 2033 from USD 45 million in 2023, expanding at a CAGR of 9.22% from 2024 to 2033 The top Companies operating in the intragastric balloon market are Allurion Technologies, Allergan (Acquired by Abbott), Apollo Endosurgery, Reshape Medical, Spatz FGIA, Endalis, Silimed, Medsil, and Others.

Intragastric Balloon Market Scope

Report Coverage Details
Growth Rate from 2024 to 2033 CAGR of 9.22%
Global Market Size in 2023 USD 45 Million
Global Market Size in 2024 USD 49.15 Million
Global Market Size by 2033 USD 108.8 Million
Largest Market North America
Base Year 2023
Forecast Period 2024 to 2033
Segments Covered By Balloon Type, By Filling Material, By Administration, and By End-use
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa


Intragastric Balloon Key Players 

  • Allurion Technologies
  • Allergan (Acquired by Abbott)
  • Apollo Endosurgery
  • Reshape Medical
  • Spatz FGIA
  • Endalis
  • Silimed
  • Medsil

Recent Developments

  • In September 2022, Allurion Technologies, the United States-based medical device manufacturer, launched its weight loss solution, a swallowable gastric balloon, in India.

We have prepared a service to support you. please feel free to contact us at sales@precedenceresearch.com | +1 804 441 9344

Keypoints

  • Company Overview
  • Locations & Subsidiaries/Geographic reach
  • Key Executives
  • Company Financials
  • Patents registered
  • SWOT Analysis
  • Corporate Strategy
  • Applications Catered
  • Strategic collaborations
  • Recent Developments
  • Competitive Benchmarking

Proceed To Buy

USD 2100

Connect with us now; your solution awaits on the other side!

Contact Us